SARS-CoV-2 infection complicated by acute longitudinally extensive transverse myelitis and pulmonary embolism: a case report - Takeaways - MDSpire

SARS-CoV-2 infection complicated by acute longitudinally extensive transverse myelitis and pulmonary embolism: a case report

  • By

  • Gulinazi Rouzi

  • Kamiernisa Wupuer

  • Ailiyaer Yasheng

  • Yang Liu

  • Reziya Apaer

  • Wumanjiang Yidayi

  • Taxi Wumiti

  • Pu Miao

  • Muhetaer Munire

  • Zhijian Li

  • Aizezi Aihemaitiniyazi

  • May 1, 2026

  • 0 min

Share

  • 1

    A 25-year-old male developed acute longitudinally extensive transverse myelitis and pulmonary embolism after SARS-CoV-2 infection.

  • 2

    The patient experienced rapid progression from chest tightness to quadriplegia and sensory deficits, confirmed by MRI.

  • 3

    Cerebrospinal fluid analysis showed inflammatory changes, despite negative results for specific antibodies.

  • 4

    Treatment with high-dose corticosteroids, anticoagulation, and antiviral agents led to partial clinical improvement.

  • 5

    This case underscores the potential for COVID-19 to cause simultaneous neurological and vascular complications.

Original Source(s)

SARS-CoV-2 infection complicated by acute longitudinally extensive transverse myelitis and pulmonary embolism: a case report

  • by Gulinazi Rouzi, Kamiernisa Wupuer, Ailiyaer Yasheng, Yang Liu, Reziya Apaer, Wumanjiang Yidayi, Taxi Wumiti, Pu Miao, Muhetaer Munire, Zhijian Li, Aizezi Aihemaitiniyazi

  • May 1, 2026

Related Content

Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review

COVID-19 webinar: COVID-19 and the rapid transition to a virtual practice

John D. Halamka, M.D., M.S., president of the Mayo Clinic Platform, and other Mayo Clinic experts discuss advanced telemedicine and the role this alternative care setting will play amid an evolving health care landscape. (Credit is available.)

  • September 3, 2020

  • 1 min
COVID-19 and financial toxicity in patients with renal cell carcinoma